Biotechnology
Investing News
Market News
Technology
Biogen Reveals New Data From Multiple Sclerosis Treatment Portfolio
Biogen Inc. (NASDAQ: BIIB) announced Tuesday new data from its robust multiple sclerosis (MS) treatment portfolio. Additional clinical data support VUMERITY® (diroximel fumarate) as an important oral treatment option in...